Mustang Bio, Inc. logo

Mustang Bio, Inc.

NASDAQ:MBIO

Overview | Financials
Company Name Mustang Bio, Inc.
Symbol MBIO
Currency USD
Price 0.254
Market Cap 9,238,710
Dividend Yield 0%
52-week-range 0.128 - 2.534
Industry Biotechnology
Sector Healthcare
CEO Dr. Manuel Litchman M.D.
Website https://www.mustangbio.com

An error occurred while fetching data.

About Mustang Bio, Inc.

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies

Related Stocks

ImmuCell Corporation logo

ImmuCell Corporation

ICCC

3.6 USD

Neuronetics, Inc. logo

Neuronetics, Inc.

STIM

0.945 USD

Silver Spike Investment Corp. logo

Silver Spike Investment Corp.

SSIC

11.74 USD

Great Elm Group, Inc. logo

Great Elm Group, Inc.

GEG

1.88 USD

LifeMD, Inc. logo

LifeMD, Inc.

LFMD

5.24 USD

Curis, Inc. logo

Curis, Inc.

CRIS

5.86 USD

Cyteir Therapeutics, Inc. logo

Cyteir Therapeutics, Inc.

CYT

3.02 USD

Financials

Numbers are in millions USD

Numbers are in millions USD